| |
| HOUSE OF COMMONS |
|
CHAMBRE DES COMMUNES |
| 2nd Session, 39th Parliament |
|
2e Session, 39e législature |
|
|
|
| NOTICE OF MEETING |
|
AVIS DE CONVOCATION |
| |
| Standing Committee on Health |
|
Comité permanent de la santé |
| |
| Meeting No. 25 | | Séance no 25 |
| Tuesday, April 29, 2008 | | Le mardi 29 avril 2008 |
| 11:00 a.m. to 1:00 p.m. | | 11 heures à 13 heures |
| Room 253-D, Centre Block |
|
Pièce 253-D, édifice du Centre |
| (613-996-4916) |
|
(613-996-4916) |
|
| |
|
|
|
| |
| Orders of the Day |
|
Ordre du jour |
| |
| |
| Post-Market Surveillance of Pharmaceutical Products | | Surveillance post-commercialisation des produits pharmaceutiques |
| |
| 11:00 a.m. to 12:00 p.m. | | 11 heures à 12 heures |
| |
| Videoconference - Silver Spring | | Vidéoconférence - Silver Spring |
| |
| Witnesses | | Témoins |
| |
| U.S. Food and Drug Administration | | U.S. Food and Drug Administration |
| |
Gerald Dal Pan, Director
Office of Surveillance and Epidermiology, Center for Drug Evaluation and Research | | Gerald Dal Pan, directeur
Office of Surveillance and Epidermiology, Center for Drug Evaluation and Research |
| |
| 12:00 p.m. to 1:00 p.m. | | 12 heures à 13 heures |
| |
| Witnesses | | Témoins |
| |
| As an individual | | À titre personnel |
| |
Jean-Pierre Ménard, Attorney and Specialist in Medical Law
Ménard, Martin, Avocats | | Jean-Pierre Ménard, avocat et spécialiste en droit médical
Ménard, Martin, Avocats |
| |
| Brogan Inc. | | Brogan inc. |
| |
| Tom Brogan, President and Chief Executive Officer | | Tom Brogan, président-directeur général |
| |
| |
| La greffière du Comité |
| Carmen DePape ((613) 995-4108) |
| Clerk of the Committee |
| |
| 2008/04/22 4:28 p.m. |
|
2008/04/22 16 h 28 |